Coronavirus / COVID-19 Pandemic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Sam	6/7/2024 4:26:01 PM
	Read Replies (1) of 22882

Stanford Medicine trial: 15-day Paxlovid regimen safe but adds no clear long-COVID benefit Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms. med.stanford.edu

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next